New Company Officers Appointed After Promising Preclinical Data on Gene Therapy for Anti-Tumor Mechanisms :NASDAQ: GNPX
Genprex, Inc. Names New Leadership Following Breakthrough Preclinical Results in Cancer Gene Therapy: Genprex, Inc. (NASDAQ: GNPX) Genprex, Inc. (NASDAQ:GNPX) AUSTIN, TEXAS, , UNITED STATES, May 13, 2024 /EINPresswire.com/ -- New Company …